Current Edition


FDA panel supports agency push to raise approval bar for certain cancer drugs

The Food and Drug Administration appears ready to raise its approval standards for a well-known class of cancer drugs due to concerns they aren’t helping …

Continue Reading →

Sarepta, with new Duchenne results, to broach ‘possibility’ of speedy gene therapy approval

Dive Brief: Sarepta Therapeutics on Monday presented new results from a placebo-controlled study of its experimental gene therapy for Duchenne muscular dystrophy, a closely watched …

Continue Reading →